There was no significant predicted change in missed cancers (+8 compared to ≥ 40 f‐Hb cut off [95% CI –43 to 63] and +9 compared to ≥ 10 f‐Hb cut off [95% CI –3 to 29]). Here, GSTM1 is linked to cancer.